Orange Book product · Brand (NDA)

LIQREV

SILDENAFIL CITRATE

Brand (NDA)NDA 214952DISCN CMP DEV LLC

Apr 28, 2023

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Apr 28, 2023
3 yr 2 mo ago
Today
Patent 11337979 expires
Listed drug product patent expiration.
Dec 24, 2038
in 12 yr 8 mo
Patent 11464778 expires
Listed drug product patent expiration.
Dec 24, 2038
in 12 yr 8 mo
Patent 11759468 expires
Listed drug product patent expiration.
Dec 24, 2038
in 12 yr 8 mo
Patent 12005062 expires
Listed drug product patent expiration.
Dec 24, 2038
in 12 yr 8 mo
Patent 12186321 expires
Listed drug product patent expiration.
Dec 24, 2038
in 12 yr 8 mo

Active ingredient

SILDENAFIL CITRATE

Strength

EQ 10MG BASE/ML

Dosage form

SUSPENSION

Route

ORAL

TE code

Not listed

Application

NDA 214952

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
11337979	Dec 24, 2038	in 12 yr 8 mo	ProductU-3582
11464778	Dec 24, 2038	in 12 yr 8 mo	ProductU-3582
11759468	Dec 24, 2038	in 12 yr 8 mo	ProductU-3582
12005062	Dec 24, 2038	in 12 yr 8 mo	ProductU-3582
12186321	Dec 24, 2038	in 12 yr 8 mo	ProductU-3582